All tissues surrounding both primary and secondary tumors showed a significant higher expression of LC3 mRNA levels compared to the tumorous tissues (PHCC vs HCC: q = 0.03 and PM vs M: q = 0.0007). The gene discussed is MAP1LC3A; the disease is hepatocellular carcinoma.